IL-17A

Neal L Millar1, Iain B McInnes2, Frank Kolbinger3

  • 1School of Infection and Immunity, University of Glasgow, Glasgow, UK neal.millar@glasgow.ac.uk.

RMD open
|February 23, 2025
PubMed
概括

干白素17A (IL-17A) 通过促进炎症和退化来驱动肌病. 阻断IL-17A通路显示出作为早期肌病的治疗策略的潜力.